These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of the fibroblast in Dupuytren's contracture. Murrell GA. Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989 [Abstract] [Full Text] [Related]
3. [Etiology of Dupuytren's contracture]. Bobiński R. Chir Narzadow Ruchu Ortop Pol; 2008 Nov; 73(4):232-5. PubMed ID: 18847012 [Abstract] [Full Text] [Related]
4. Anatomy and pathogenesis of the digital cords and nodules. Strickland JW, Leibovic SJ. Hand Clin; 1991 Nov; 7(4):645-57; discussion 659-60. PubMed ID: 1769987 [Abstract] [Full Text] [Related]
5. An insight into Dupuytren's contracture. Murrell GA. Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255 [Abstract] [Full Text] [Related]
6. [Dupuytren's contracture and diabetes mellitus]. Fossati P, Romon M, Vennin P. Ann Chir Main; 1982 May; 1(4):351-4. PubMed ID: 9382632 [Abstract] [Full Text] [Related]
7. Etiology of Dupuytren's disease. Yi IS, Johnson G, Moneim MS. Hand Clin; 1999 Feb; 15(1):43-51, vi. PubMed ID: 10050241 [Abstract] [Full Text] [Related]
8. The anatomy of Dupuytren's disease. McFarlane RM. Bull Hosp Jt Dis Orthop Inst; 1984 Feb; 44(2):318-37. PubMed ID: 6099177 [Abstract] [Full Text] [Related]
9. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis. Hamamoto H, Ueba Y, Sudo Y, Sanada H, Yamamuro T, Takeda T. Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030 [Abstract] [Full Text] [Related]
10. Clinical associations of Dupuytren's disease. Hart MG, Hooper G. Postgrad Med J; 2005 Jul; 81(957):425-8. PubMed ID: 15998816 [Abstract] [Full Text] [Related]
11. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Vi L, Feng L, Zhu RD, Wu Y, Satish L, Gan BS, O'Gorman DB. Exp Cell Res; 2009 Dec 10; 315(20):3574-86. PubMed ID: 19619531 [Abstract] [Full Text] [Related]
12. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. J Surg Res; 2002 Apr 10; 103(2):146-52. PubMed ID: 11922728 [Abstract] [Full Text] [Related]
13. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target. Verjee LS, Verhoekx JS, Chan JK, Krausgruber T, Nicolaidou V, Izadi D, Davidson D, Feldmann M, Midwood KS, Nanchahal J. Proc Natl Acad Sci U S A; 2013 Mar 05; 110(10):E928-37. PubMed ID: 23431165 [Abstract] [Full Text] [Related]
14. [Etiology, pathomechanism and therapy of Dupuytren's contracture]. Sonecki P, Olczyk K. Wiad Lek; 1992 Jul 05; 45(13-14):519-22. PubMed ID: 1462571 [No Abstract] [Full Text] [Related]
15. The microanatomy of Dupuytren's contracture. McGrouther DA. Hand; 1982 Oct 05; 14(3):215-36. PubMed ID: 7152372 [Abstract] [Full Text] [Related]
16. Scientific comment. Basic science of Dupuytren's disease. Murrell GA. Ann Chir Main Memb Super; 1992 Oct 05; 11(5):355-61. PubMed ID: 1284015 [Abstract] [Full Text] [Related]
17. Free radicals and Dupuytren's contracture. Murrell GA, Francis MJ, Bromley L. Br Med J (Clin Res Ed); 1987 Nov 28; 295(6610):1373-5. PubMed ID: 2825907 [Abstract] [Full Text] [Related]
18. Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. Alioto RJ, Rosier RN, Burton RI, Puzas JE. J Hand Surg Am; 1994 May 28; 19(3):442-52. PubMed ID: 8056971 [Abstract] [Full Text] [Related]
19. New insights in the development of Dupuytren's contracture: a review. Kloen P. Br J Plast Surg; 1999 Dec 28; 52(8):629-35. PubMed ID: 10658134 [Abstract] [Full Text] [Related]
20. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease. Gudmundsson KG, Arngrimsson R, Jónsson T. Scand J Rheumatol; 2001 Dec 28; 30(1):31-4. PubMed ID: 11252689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]